Skip to main content
Year archive

Vor Biopharma Inc. — 2022 filings

All 45 regulatory filings released by Vor Biopharma Inc. (VOR) in 2022, sourced directly from the official regulator.

45 Filings
2022 Period
2022 filings (45)
Filing Released Lang
8-K
Regulatory Filings
2022-12-23 English
Prospectus
2022-12-23 English
Regulatory Filings
2022-12-21 English
Regulatory Filings
2022-12-16 English
Regulatory Filings
2022-12-16 English
S-3
Registration Form
2022-12-14 English
8-K
Regulatory Filings
2022-12-14 English
Director's Dealing
2022-12-09 English
Major Shareholding Notification
2022-12-09 English
Prospectus
2022-12-08 English
8-K
Regulatory Filings
2022-12-07 English
8-K
Regulatory Filings
2022-12-07 English
8-K
Regulatory Filings
2022-11-29 English
Major Shareholding Notification
2022-11-14 English
Interim / Quarterly Report Q3 2022
2022-11-10 English
Major Shareholding Notification
2022-10-27 English
Director's Dealing
2022-10-12 English
Director's Dealing
2022-10-12 English
Director's Dealing
2022-09-15 English
Director's Dealing
2022-09-06 English
Director's Dealing
2022-09-06 English
Interim / Quarterly Report Q2 2022
2022-08-11 English
Director's Dealing
2022-06-17 English
8-K
Regulatory Filings
2022-06-17 English
Director's Dealing
2022-06-16 English
Director's Dealing
2022-06-16 English
Director's Dealing
2022-06-16 English
Director's Dealing
2022-06-16 English
Director's Dealing
2022-06-16 English
Director's Dealing
2022-06-16 English
Interim / Quarterly Report Q1 2022
2022-05-12 English
Regulatory Filings
2022-04-28 English
Proxy Solicitation & Information Statement
2022-04-28 English
8-K
Regulatory Filings
2022-04-14 English
Regulatory Filings
2022-03-21 English
Regulatory Filings
2022-03-16 English
Regulatory Filings
2022-03-16 English
S-3
Registration Form
2022-03-14 English
S-8
Registration Form
2022-03-14 English
Annual Report FY 2021
2022-03-14 English
Major Shareholding Notification
2022-02-09 English
Director's Dealing
2022-02-03 English
Director's Dealing
2022-02-03 English
Director's Dealing
2022-02-03 English
Director's Dealing
2022-02-03 English